Achieve Life Sciences, Inc.
ACHV
Rank in Stocks
#10423
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm,... Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
Share Price
$6.78
Last synced: 2026-11-09
Market Cap
$697.68M
Change (1 day)
0.89%
Change (1 year)
42.14%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Achieve Life Sciences, Inc. (ACHV)
Category
Healthcare
Operating Margin for Achieve Life Sciences, Inc. (ACHV)
Operating Margin as of November 2026 TTM: 0.00%
According to Achieve Life Sciences, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Achieve Life Sciences, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | -418.65% | 305.39% |
| 2015 | -103.27% | -4.97% |
| 2014 | -108.67% | -8.08% |
| 2013 | -118.22% | -8.58% |
| 2012 | -129.32% | -68.11% |
| 2011 | -405.51% | 274.47% |
| 2010 | -108.29% | 1,022.18% |
| 2009 | -9.65% | -68.98% |
| 2008 | -31.11% | -58.89% |
| 2007 | -75.68% | -35.53% |
| 2006 | -117.39% | -55.57% |
| 2005 | -264.21% | 4,120.61% |
| 2004 | -6.26% | -99.99% |
| 2003 | -42,552.60% | -12.62% |
| 2002 | -48,696.39% | -1,971,613.77% |
| 2001 | 2.47% | -100.14% |
| 2000 | -1,770.96% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Achieve Life Sciences, Inc.'s operating margin
What was Achieve Life Sciences, Inc.'s operating margin in 2025?
In 2025, Achieve Life Sciences, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Achieve Life Sciences, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Achieve Life Sciences, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does Achieve Life Sciences, Inc.'s operating margin compare with similar companies?
Achieve Life Sciences, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.